Search results
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 7 hours agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Company News For May 13, 2024
Zacks via Yahoo Finance· 4 days agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 3 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agovaccine has demonstrated strong protection to date, and we will be interested to see if mRNA ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 4 days agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 4 days agoHe did not provide specific timing but emphasized these are strategic...some light on the branding message and the future commercialization of Sanofi and Novavax branded products ...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 3 days agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...